Financials
Financial year 2025
PHARMACIE DU SACRE - COEUR from Tournai, company number BE0442155001, closed financial year 2025 with a result of € -24,008 after tax. For that financial year PHARMACIE DU SACRE - COEUR recorded a gross margin of € 403,608 and equity of € 595,936. Compared with financial year 2024, the result moved from € 70,510 to € -24,008. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 595,936
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -24,008
▼ still € 70,510 profit in 2024
Profit after tax over the fiscal year.
€ 128,878
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 447,200.
People and assets in 2025
5.1
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 329,724
▲ 21% vs 2024
€ 64,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 24,067
▼ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 218,462
▼ 15% vs 2024
€ 56,798 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 131,082
▲ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 52,245
▲ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 460,346 | € 511,226 | € 507,937 | € 403,608 | ▼ 21% |
| Profit after taxes | € 75,816 | € 67,849 | € 70,510 | € -24,008 | ▼ € 94,518 |
| Equity | € 548,584 | € 549,434 | € 619,944 | € 595,936 | ▼ 4% |
| Total debts | € 589,788 | € 461,558 | € 433,625 | € 404,918 | ▼ 7% |
| Cash | € 145,201 | € 24,831 | € 138,769 | € 128,878 | ▼ 7% |
| Land & buildings | € 284,000 | € 266,000 | € 248,000 | € 405,397 | ▲ 63% |
| Retained profit | € 399,848 | € 400,698 | € 471,207 | € 447,200 | ▼ 5% |
| Dividend | € 75,000 | € 67,000 | € 0 | € 0 | |
| Bank debt | € 342,180 | € 295,953 | € 256,916 | € 218,462 | ▼ 15% |
| Balance sheet total | € 1,138,372 | € 1,010,991 | € 1,053,569 | € 1,000,854 | ▼ 5% |
| Employees (FTE) | 4.8 | 4.8 | 4.6 | 5.1 | ▲ 0.5 |
Key figures of PHARMACIE DU SACRE - COEUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DU SACRE - COEUR?
What happened at PHARMACIE DU SACRE - COEUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 24,008 (▼ € 94,518 vs 2024). Source: NBB ↗
- BNA SANTE SRL became a director. NBB
- New establishment in Tournai. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,816 profit in 2022 to € 24,008 loss in 2025.
Paid € 75,016 in corporate taxes since 2022.
Best year ever: 2022, with € 75,816 profit.
On average € 79,100 of value added per employee in 2025.
A new publication or filing at PHARMACIE DU SACRE - COEUR? We notify you, reason included.
Follow PHARMACIE DU SACRE - COEURDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of BNA Santé, FDIR management comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DU SACRE - COEURBehind PHARMACIE DU SACRE - COEUR is BNA SANTE SRL. The shares are held by BNA Santé (100%) and FDIR management (96%).
Directors
According to the 2025 annual accounts
Director · represented by Nathalie Schleich
Also active at: PHARMACIE ANSELME, PHARMACIE DE LA VERTE FEUILLE, Pharmaplus Grand Place, Pharmaplus Detimmerman
since 2024
Shareholders
100%
96%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée de Renaix(TOU) 48
7500 Tournai
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.155.001
- VAT number
- BE 0442.155.001
- Registered office
- Chaussée de Renaix(TOU) 48, 7500 Tournai
- Names & denominations
- PHARMACIE DU SACRE - COEUR
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 October 1990
- Peppol
- Active · Active since 3 Oct 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Bemiddeling in verband met exploitatie van en handel in onroerend goed
Bemiddeling bij de aankoop, verkoop en verhuur van onroerend goed voor een vast bedrag of op contractbasis